FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Elan topics
Folic Acid
Carbon Dioxide
Antibodies
Immune Response
High Energy
Inorganic Compounds
Electrolysis
Semiconductor Material
Semiconductor
Hydrogen Production From Water
Female Sexual Dysfunction
Dysfunction
Sexual Dysfunction
Mammography
Radiograph

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Elan patents



      
           
This page is updated frequently with new Elan-related patent applications. Subscribe to the Elan RSS feed to automatically get the update: related Elan RSS feeds. RSS updates for this page: Elan RSS RSS


Date/App# patent app List of recent Elan-related patents
08/21/14
20140235488
 Microrna patterns for the diagnosis, prognosis and treatment of melanoma patent thumbnailnew patent Microrna patterns for the diagnosis, prognosis and treatment of melanoma
The present invention relates to methods for diagnosing, staging, prognosticating and treating melanoma based on evaluating the expression of specific patterns of oncogenic or suppressive microrna (mir) molecules in a patient in need thereof.. .
08/21/14
20140235443
 Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and propyzamide patent thumbnailnew patent Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and propyzamide
Or an agriculturally acceptable salt or ester thereof and (b) propyzamide provide control of undesirable vegetation, e.g., in winter/spring oilseed rape, winter/spring canola, vegetables, brassica spp, ornamentals, rice, wheat, triticale, barley, oats, rye, sorghum, corn/maize, sunflower, row crops, pastures, grasslands, rangelands, fallowland, sugarcane, turf, tree and vine orchards, and industrial vegetation management and rights-of-way.. .
08/21/14
20140234324
 Methods for treating a tumor using an antibody that specifically binds grp94 patent thumbnailnew patent Methods for treating a tumor using an antibody that specifically binds grp94
Combinations of agents that have a synergistic effect for the treatment of a tumor are disclosed herein. These combinations of agents can be used to treat tumors, wherein the cells of the cancer express a mutated braf.
08/21/14
20140231284
 Transportable hybrid power system patent thumbnailnew patent Transportable hybrid power system
A transportable, deployable power system comprising a hybrid power box containing solar panels, wind turbine(s), fuel cells, fuel reformers, and other energy sources. The system could also include waste water and potable water inlet and outlet ports for water treatment.
08/14/14
20140227779
 Melanocyte or progenitor cell thereof adapted to keratinocyte, and preparation method thereof patent thumbnailMelanocyte or progenitor cell thereof adapted to keratinocyte, and preparation method thereof
The present invention relates to novel melanocytes and melanoblasts. In addition, the present invention relates to a novel method for producing melanocytes and melanoblasts.
08/14/14
20140227323
 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens patent thumbnailRecombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
An immunogenic composition comprising a recombinant protein comprising a bordetella cyaa, or a fragment thereof, and a peptide that corresponds to a tumor antigen is provided as a cancer treatment. Methods of treatment with this immunogenic composition are also provided.
08/07/14
20140221658
 Inhibition of cell proliferation patent thumbnailInhibition of cell proliferation
The disclosed modulators of rb:raf-1 interactions are potent, selective disruptors of rb:raf-1 binding, with ic50 values ranging from 80 nm to 500 nm. Further, these compounds are surprisingly effective in inhibiting a wide variety of cancer cells, including osteosarcoma, epithelial lung carcinoma, non-small cell lung carcinoma, three different pancreatic cancer cell lines, two different glioblastoma cell lines, metastatic breast cancer, melanoma, and prostate cancer.
08/07/14
20140221496
 Method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm patent thumbnailMethod of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm
The invention provides diagnostic and therapeutic methods for neoplastic disease patients with neoplasms of, for example, the breast, skin, kidney, lung, pancreas, rectum and colon, prostate, bladder, epithelial, non-epithelial, lymphomas, sarcomas, melanomas, and the like, wherein the method comprises determining the level of expression o caveolin-1, caveolin-2, vimentin, calponin2, tropomyosin, gelsolin, prolyl 4-hydroxylase alpha, ef-i-delta, or m2-isoform of pyruvate kinase in stromal cells adjacent to the neoplasm.. .
08/07/14
20140221293
 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same patent thumbnailFish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same
The present invention relates to a fish protein hydrolysate having a biological activity of interest, in particular an effect on the stimulation and maintenance of bone. The fish protein hydrolysate is characterized in that it is obtained by enzymatic hydrolysis of at least one protein source selected from the fish species micromesistius poutassou, clupea harengus, scomber scombrus, sardina pilchardus, trisopterus esmarki, trachurus spp, gadus morhua, pollachius virens, melanogrammus aeglefinus and coryphaenoides rupestris, and the species of fish belonging to the order siluriformes, said enzymatic hydrolysis being carried out by means of an endopeptidase enzyme derived from bacillus subtilis.
08/07/14
20140220032
 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma patent thumbnailDdr2 mutations as targetable features of melanoma or basal cell carcinoma
Described herein are methods for diagnosing melanoma or basal cell carcinoma based on mutations in the ddr2 gene. Further, a distinct subgroup of braf-mutated melanomas have somatic mutations in the ddr2 gene as well.
08/07/14
20140220022
Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
The present invention is directed to the diagnosis and treatment of diseases, preferably the inhibition of tumor growth and its progression to metastatic sites, through the inhibition of the production of pthrp, its isoforms or pthrp signalling. The present invention is also directed to methods of inhibiting the pthrp1-173 isoform through antagonists thereof, including monoclonal antibodies and sirna directed there against.
08/07/14
20140219998
Armet as a marker for cancer
Disclosed is a method aiding in the assessment of cancer. More specifically disclosed is the use of the arginine-rich metastasized in early tumors protein (=armet) as a universal marker of different cancer types.
08/07/14
20140219940
Skin-lightening agent
Provided are a very safe skin whitening agent, melanin production inhibitor, and dopa oxidase activity inhibitor. Use of kitsunenomago or an organic solvent extract thereof to inhibit the dopa oxidase activity..
07/31/14
20140213591
Histone demethylase inhibitors
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted amidopyridine or amidopyridazine derivative compounds and pharmaceutical compositions comprising said compounds.
07/31/14
20140213452
Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and picloram or a derivative thereof
E.g., rice, wheat, barley, triticale, oats, rye, sorghum, corn or maize, oilseed rape, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, aquatics, industrial vegetation management or rights-of-way.. .
07/31/14
20140213447
Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or a derivative thereof and certain triazolopyrimidine sulfonamides
Or an agriculturally acceptable salt or ester thereof and (b) diclosulam or clorasulam-methyl or an agriculturally acceptable salt thereof provide control of undesirable vegetation in, e.g., rice, wheat, barley, oats, rye, sorghum, corn or maize, oilseed rape, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, aquatics, industrial vegetation management or rights-of-way.. .
07/31/14
20140213446
Herbicidal compositions and methods using combinations of 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and an aryloxyphenoxy propionate accase inhibitor herbicide
Or an agriculturally acceptable salt or ester thereof and (b) an aryloxyphenoxy propionate accase inhibitor herbicide selected from the group consisting of fluazifop-p, haloxyfop-p, and quizalofop-p or an agriculturally acceptable salt or ester thereof provide control of undesirable vegetation in, e.g., rice, wheat, barley, triticale, oats, rye, sorghum, corn or maize, oilseed rape, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, aquatics, industrial vegetation management (ivm) or rights-of-way.. .
07/24/14
20140206957
Method and optical system for evaluating concentrations of components in tissue
A method and an optical system for evaluating the spatial distribution of the concentrations of components in tissue are disclosed. The novel detecting probe included in the optical system comprises plural optical fiber sets, each optical fiber set respectively comprises at least one source optical fiber and at least one detector optical fiber, the source optical fiber connects with the multi-wavelength light source, the source optical fiber delivers light from the multi-wavelength light source onto a tested tissue; and the angle between one optical fiber set and another optical fiber set is greater than 0° and less than and not equal to 180°.
07/24/14
20140205685
Herbal combinations for treatment of a skin condition
A method and medicine for treating melanoma, bcc (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, comprising applying or injecting to an infected skin area of a patient diagnosed with melanoma, bcc (basal cell carcinoma) or psoriasis or other inflammatory skin disease, or a combination thereof, a treatment regimen that includes periodic doses of a molecular combination of emodin and digoxin and/or an herbal combination of da huang and sheng di huang.. .
07/17/14
20140199378
New natural and synthetic compounds for treating cancer and other diseases
This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or inhibitor of adhesion proteins and angiopoietins.
07/10/14
20140194632
Method for screening for compounds selectively interacting with rad9
Natural and synthetic compounds of formulae ia-ie having a lactone structure, in particular securolide, have been determined to be effective anti-tumor compounds which target the hrad9 gene and/or protein encoded thereby or complex containing the protein and/or the p53 gene and/or protein. Securolide is cytoselective for mutants of hrad9 based on studies conducted in rad9 mutant yeast strains.
07/10/14
20140194495
Cytotoxin compounds and methods of isolation
The present invention concerns groups of compounds derived from tunicates of the synoicum species, as well as to pharmaceutical compositions comprising these compounds, and uses thereof. Extracts from tunicates show selective toxicity against several different cancer cell lines in the nci 60 cell line panel.
07/10/14
20140194469
Histone demethylase inhibitors
Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase.
07/10/14
20140193479
Compositions and methods for treatment of mammalian skin
Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure.
07/10/14
20140193478
Compositions and methods for treatment on mammalian skin
Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure.
07/10/14
20140193349
Use of cannabinoid compounds for stimulating melanogenesis
It being understood that, when r3 and r4 together form an oxo group with the carbon atom which bears them and x represents an oxygen atom, then r1 cannot represent a hydroxymethyl group, as an agent for coloring keratin materials. It also relates to one of these specific cannabinoid compounds for use thereof in the treatment of vitiligo or pityriasis versicolor, to nontherapeutic cosmetic processes for coloring the skin or for treating canities, comprising the topical application to the skin and/or head hair, or the oral administration, of a composition comprising, in a physiologically acceptable medium, one of these cannabinoid compounds, and to a process for selecting an active agent which promotes the pigmentation of keratin materials..
07/03/14
20140188196
Methods for weight treatment in animals utilizing narrow spectrum light
Methods of weight treatment in animals are presented including: stimulating a retinal ganglia of the animal by an exposure to a narrow spectrum light. In some embodiments, the stimulating the retinal ganglia of the animal is associated with a stimulation of melanopsin.
07/03/14
20140187469
Aqueous formulation for dispensing as a spray polymeric microcapsules containing at least one active ingredient
An aqueous formulation for dispensing as a spray polymeric microcapsules containing at least one active ingredient, the aqueous formulation comprising: (i) water; (ii) polymeric microcapsules having an oil-soluble core containing the at least one active ingredient; (iii) a cross linked acrylic acid co-polymer; (iv) a neutralising amine for activating the cross linked acrylic acid copolymer to form a gel suspension for the polymeric microcapsules whereby the polymeric microcapsules are suspended in the water; (v) a chelant for protecting the aqueous formulation against destabilisation by excessive metal ions; and (vi) an inhibitor for inhibiting bacterial growth in the water.. .
07/03/14
20140186295
Methods and compositions for the treatment of cancer
Described herein are methods for the treatment of cancer (e.g. Melanoma, lung cancer, or other cancers).
06/26/14
20140179736
Method of treating cancer and bone cancer pain
This invention is directed to the treatment of cancer, particularly lung cancer, breast cancer, melanoma, renal cell carcinoma, thyroid cancer that has metastasized to the bone. The invention is also directed to a method for treating bone cancer pain in an individual in need of such treatment comprising administering to the individual an effective amount of a compound of formula i..
06/26/14
20140179693
Methods for treating vascular leak syndrome
Disclosed are methods for treating vascular leak syndrome. Further disclosed are methods for treating vascular leakage due to inflammatory diseases, inter alia, sepsis, lupus, inflammatory bowel disease.
06/26/14
20140179525
Herbicidal compositions comprising fluroxypyr and flumetsulam
Herbicidal compositions containing (a) fluoroxypyr or an agriculturally acceptable salt or ester thereof and (b) flumetsulam or an agriculturally acceptable salt thereof provide synergistic herbicidal control of undesirable vegetation, e.g., in wheat, barley, oats, rye, sugarcane, rice, sorghum, corn/maize, soybean, rice, sunflower, canola/oilseed rape, sugarcane, sorghum, cotton, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, industrial vegetation management and rights-of-way; or crops comprising an aad-12 gene. Also provided herein are methods of using herbicidal compositions containing (a) fluoroxypyr or an agriculturally acceptable salt or ester thereof and (b) flumetsulam or an agriculturally acceptable salt thereof..
06/26/14
20140178430
Idna vaccines and methods for using the same
Described herein are idna vectors and vaccines and methods for using the same. The idna generates live attenuated vaccines in eukaryotic cells in vitro or in vivo for pathogenic rna viruses, particularly yellow fever virus and venezuelan equine encephalitis virus.
06/26/14
20140178376
Method of inhibiting osteoclast activity
Methods for inhibiting osteoclastogenesis by administering a soluble rank polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer..
06/26/14
20140178319
Modulation of melanogenesis by modification of tyrosinase by palmitoylation
Compositions and methods for modulating melanogenesis by modifying tyrosinase palmitoylation are provided.. .
06/26/14
20140177808
Rapidly switching dual energy x-ray source
A dual energy x-ray source for use in homeland security, medical, non-destructive testing, and other markets includes a power supply, and a single x-ray tube. The x-ray tube includes two cathodes, and a single anode.
06/19/14
20140172322
Anti-terrorism water quality monitoring system
An anti-terrorism water quality monitoring system for continuously monitoring a potable water treatment system and related potable water distribution network that provides potable water to a municipality, city, housing development or other potable water consumer. The system includes the collection of data from the water distribution system and from the water treatment facility and from advanced separation processes which are integrated into analytical instruments.
06/19/14
20140171432
Histone demethylase inhibitors
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted 3-aminopyridine derivative compounds, substituted 3-aminopyridazine derivative compounds, and pharmaceutical compositions comprising said compounds.
06/19/14
20140171376
Light-sensitive chimeric gpcr protein
A light-sensitive chimeric protein comprising domains from at least two members of the g-protein-coupled-receptor (gpcr) protein super family, which are fused to yield a light-sensitive gpcr chimera capable of coupling a light signal to the signaling cascade of the metabotropic glutamate receptor 6 (mglur6) is provided for medical therapy and for the manufacture of medicaments for improving vision, in particular for treating loss of vision resulting from retinal photoreceptor degeneration. A first of the at least two gpcr family members contributes domains which mediate the light-sensitivity to the chimeric light-sensitive gpcr protein.
06/19/14
20140169698
Method for image fusion based on principal component analysis
An image fusion method combines absorption, differential phase contrast and dark-field (scattering) signals obtained with x-ray phase contrast sensitive techniques, such as an arrangement of gratings. The process fuses the absorption and dark-field signals by principal component analysis.
06/19/14
20140167024
Display apparatus
Provided is a display apparatus and a method of manufacture. The display apparatus includes a first substrate with a plurality of organic electroluminescence devices, a second substrate with a color filter, the second substrate facing the first substrate, and an adhesive layer disposed between the first substrate and the second substrate so as to cover the plurality of organic electroluminescence devices, the adhesive layer being made of a material selected from the group consisting of a phenol resin, a melanin resin, an unsaturated polyester resin, an epoxy resin, a silicon resin and a polyurethane resin..


Popular terms: [SEARCH]

Elan topics: Folic Acid, Carbon Dioxide, Antibodies, Immune Response, High Energy, Inorganic Compounds, Electrolysis, Semiconductor Material, Semiconductor, Hydrogen Production From Water, Female Sexual Dysfunction, Dysfunction, Sexual Dysfunction, Mammography, Radiograph

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Elan for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elan with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3512

3053

7 - 0 - 71